- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Salivary Gland Carcinoma in Portugal
Total 394 results
-
Arcus Biosciences, Inc.Gilead Sciences; Taiho Pharmaceutical Co., Ltd.Active, not recruitingAdvanced Upper Gastrointestinal Tract AdenocarcinomaKorea, Republic of, Spain, United States, France, United Kingdom, China, Israel, Poland, Japan, Hungary, Australia, Malaysia, Serbia, Thailand, Canada, Lithuania, Italy, Philippines, Portugal, Brazil, Argentina, Romania, Peru, Hong Kong, Chi... and more
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMetastatic Non-Small Cell Lung CancerRussian Federation, Australia, United States, Argentina, Canada, Colombia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Puerto Rico, Spain, United Kingdom
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Italy, Korea, Republic of, Poland, Russian Federation, Spain, United Kingdom, China, Romania, Netherlands, Hong Kong, Austria, Belgium, Czechia, Hungary, Portugal, Greece, Germany, Ireland, Switze... and more
-
Eli Lilly and CompanyCompletedPancreatic Neoplasms | Metastases, NeoplasmUnited States, France, United Kingdom, Germany, Taiwan, Spain, Belgium, Portugal, Peru, Austria, Italy, Sweden, Netherlands, Venezuela, Argentina, Australia, Colombia, Greece
-
Taiho Oncology, Inc.TerminatedMetastatic Diffuse Gastric Cancer Including Carcinoma of the Gastro-esophageal JunctionBelgium, Spain, United States, Italy, Estonia, Russian Federation, Bulgaria, Hungary, Croatia, Israel, Mexico, Poland, Portugal, Romania, South Africa, Ukraine, United Kingdom, Brazil, Germany, Argentina
-
European Organisation for Research and Treatment...CompletedTesticular Germ Cell Tumor | Ovarian Cancer | Extragonadal Germ Cell TumorFrance, Spain, Denmark, Netherlands, Norway, Belgium, United Kingdom, Israel, Italy, Switzerland, Germany, Portugal, Greece, Austria
-
PfizerCompletedDiabetes MellitusUnited States, Australia, Denmark, Netherlands, Canada, Brazil, Germany, Greece, Italy, Slovakia, Sweden, Croatia, Belgium, Poland, Spain, Portugal, Argentina, Austria, Estonia, Finland, France, Mexico, Norway, South Africa, United Kingdom
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingGastric Cancer | Esophageal Adenocarcinoma | Gastroesophageal Junction CancerUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Czechia, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Si... and more
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Belgium, United States, Australia, Portugal, Germany, Puerto Rico, Spain, Netherlands, Brazil, Finland, Norway, Poland, Sweden
-
Novartis PharmaceuticalsCompletedAcromegalyItaly, Belgium, United Kingdom, Bulgaria, Turkey, France, Portugal, China, Argentina, Brazil, Colombia, Hungary, Malaysia, Mexico, Romania
-
PfizerTerminatedDiabetes Mellitus Type 2Spain, Canada, France, Greece, Portugal, Sweden, Turkey
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Denmark, France, Ireland, Korea, Republic of, Portugal, United Kingdom
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United States, Malaysia, United Kingdom, Australia, Netherlands, Portugal, Austria, Israel, India, Greece, Lebanon, Mexico, New Zealand, North Macedonia, Puerto Rico, Romania, Russian Federation, Ukraine, Morocco, Belgium, Czechia, Taiw...
-
European Organisation for Research and Treatment...CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerFrance, Canada, Spain, Norway, Belgium, Netherlands, United Kingdom, Portugal, Austria, Denmark, Ireland, Sweden, Italy, Argentina, Germany
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Korea, Republic of, Australia, Taiwan, Hong Kong, Malaysia, Thailand, Argentina, Belgium, Portugal, Italy, Czechia, Mexico, Poland, Germany
-
AstraZenecaEnrolling by invitationBreast Cancer | Ovarian CancerItaly, Spain, United States, Canada, Belgium, Denmark, Korea, Republic of, Czechia, Turkey, China, United Kingdom, Taiwan, Brazil, Israel, France, Hungary, Poland, Portugal, Germany, Russian Federation, Bulgaria, Finland, Slovenia, Sw...
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Mexico, Israel, Taiwan, Malaysia, Hungary, Turkey, Morocco, Germany, South Africa, Portugal, Lebanon, Italy, Brazil, Croatia, Egypt, Spain, Russian Federation, Greece, Argentina, Korea, Republic of, Poland, Serbia
-
Novartis PharmaceuticalsTerminatedPainful Diabetic NeuropathyBelgium, Austria, Germany, Australia, United Kingdom, Bulgaria, Slovakia, Hungary, Spain, Portugal, France, Poland, Denmark, Norway, Canada, Finland
-
Calcilytix Therapeutics, Inc., a BridgeBio companyRecruitingAutosomal Dominant HypocalcemiaUnited States, France, Denmark, Australia, Japan, Belgium, Canada, Italy, Netherlands, United Kingdom, Portugal, Finland, Germany
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Canada, El Salvador, Germany, Italy, Portugal, Russian Federation, Spain, Ukraine
-
PfizerCompletedMacular Edema Associated With Diabetes MellitusUnited States, Colombia, Australia, Germany, Italy, South Africa, Greece, France, Austria, United Kingdom, Denmark, India, Portugal, Brazil, Canada, Czechia, Netherlands, Switzerland
-
Novo Nordisk A/SActive, not recruitingObesity | Diabetes Mellitus, Type 2United States, Canada, Hungary, Portugal, Slovakia, South Africa, Poland, Bulgaria
-
MicuRxRecruitingDiabetic Foot InfectionSpain, China, United States, Estonia, Latvia, Portugal, Bulgaria, Greece, Italy, Lithuania, Puerto Rico
-
Neurocrine BiosciencesActive, not recruitingCongenital Adrenal HyperplasiaUnited States, Spain, Belgium, Austria, Bulgaria, Canada, Czechia, France, Germany, Greece, Israel, Italy, Netherlands, Poland, Portugal, Serbia, Sweden, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Israel, Italy, Poland, Russian Federation, United Kingdom, Canada, Denmark, Sweden, Austria, Belgium, Spain, Ireland, Norway, Serbia, Finland, Portugal, Ukraine
-
AbbVieCompletedHidradenitis Suppurativa (HS)United States, Belgium, Canada, Colombia, Czechia, Denmark, France, Germany, Greece, Ireland, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Sweden, Turkey, United Kingdom
-
BayerCompletedDiabetic RetinopathyKorea, Republic of, Russian Federation, Hong Kong, Taiwan, United States, Argentina, Japan, Denmark, Israel, Spain, Sweden, China, Colombia, Italy, Portugal
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes Mellitus, Type 1Israel, United Kingdom, France, Netherlands, Spain, Finland, Malaysia, Norway, Italy, Germany, Poland, Romania, Portugal, Ireland, Croatia, Greece
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Japan, Russian Federation, Spain, Sweden, Argentina, Hungary, Norway, South Africa, Turkey, Bulgaria, Romania, Thailand, Portugal, Hong Kong, Mexico, Ukraine, Czechia
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Poland, Colombia, Mexico, Portugal, Bulgaria, India, Malaysia, Turkey, Ukraine, Greece, Sweden, Singapore, Czech Republic, Argentina, Puerto Rico, Russian Federation, Thailand, Slovakia, Latvia, Estonia, Peru
-
AstraZenecaCompletedDiabetesSpain, United Kingdom, Belgium, Portugal, Greece, Luxembourg
-
European Organisation for Research and Treatment...NCIC Clinical Trials GroupCompletedSarcoma | Kidney Cancer | Ovarian Cancer | Endometrial Cancer | PheochromocytomaFrance, Canada, Switzerland, Denmark, Belgium, Netherlands, United Kingdom, Germany, Italy, Slovakia, Spain, Portugal, Austria
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Canada, Colombia, Czech Republic, Finland, Hong Kong, India, Italy, Malaysia, Mexico, Netherlands, Norway, Philippines, Portugal, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United...
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Croatia, India, Poland, Spain, Serbia, Germany, Slovakia, Slovenia, Turkey, Hungary, Greece, Czechia, Bulgaria, South Africa, Romania, Bosnia and Herzegovina, Estonia, Portugal, Latvia, Lithuania, North Macedonia
-
AstraZenecaTerminatedType 2 DiabetesBrazil, France, Russian Federation, South Africa, Germany, Malaysia, Finland, Norway, Hong Kong, Canada, Hungary, Portugal, Taiwan, India, Philippines, Switzerland, Indonesia, Singapore
-
Boehringer IngelheimCompletedOvarian Neoplasms | Peritoneal NeoplasmsUnited States, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom
-
AmgenRecruitingSolid TumorsCanada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Japan, Czechia, Hungary, Poland, Brazil, Argentina, Denmark, Greece, Mexico, Switzerland, Romania, Italy, Finland and more
-
Bristol-Myers SquibbWithdrawnStomach Cancer | Gastric Cancer | Cancer of the Stomach | Gastroesophageal JunctionBrazil, Italy, United States, Argentina, Chile, Germany, Spain, Australia, Canada, Portugal, Mexico, Romania, Colombia, Puerto Rico
-
AmgenTerminatedGastric CancerUnited States, Italy, Belgium, Hungary, Poland, Romania, Denmark, Switzerland, Canada, France, Germany, Russian Federation, Turkey, United Kingdom, Spain, Austria, Portugal, Australia, Greece, South Africa, Bulgaria, Ukraine, Brazil, ... and more
-
Boehringer IngelheimCompletedHypertension | Diabetic NephropathiesSpain, Taiwan, Malaysia, Italy, Portugal, France, Czech Republic, Korea, Republic of, Russian Federation, Denmark, Germany, Slovakia, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, India, Russian Federation, Spain, United Kingdom, Austria, Belgium, Mexico, Sweden, Israel, Taiwan, Hungary, Malaysia, Serbia, Turkey, Denmark, Greece, Thailand, North Macedonia, Norway, Portugal, Germany, Romania and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, India, Slovakia, Spain, United Kingdom, Finland, Ireland, Germany, Greece, Puerto Rico, Romania, Bulgaria, Latvia, Hong Kong, Lithuania, Portugal
-
Novo Nordisk A/SRecruitingObesity | Diabetes Mellitus, Type 2United States, Spain, Portugal, Italy, Greece, Romania, Czechia, Slovakia, South Africa, Ukraine
-
AbbottCompletedDiabetic Nephropathy | Chronic Kidney DiseaseUnited States, Germany, Greece, Italy, Netherlands, Poland, Portugal, Puerto Rico, Spain, Taiwan
-
Novartis PharmaceuticalsCompletedDiabetic Macular EdemaBelgium, United Kingdom, Netherlands, Ireland, Switzerland, Italy, Hungary, France, Spain, Portugal, Poland, Czech Republic, Greece
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Korea, Republic of, China, Spain, Taiwan, Japan, Argentina, Canada, Croatia, Greece, Ireland, Malaysia, Netherlands, Portugal, Romania, Thailand, Turkey, United Kingdom
-
AmgenCompletedSecondary HyperparathyroidismUnited States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Finland, Taiwan, United States, Korea, Republic of, China, Australia, Portugal, Japan, India, Russian Federation, Norway, Italy, Mexico, Turkey, Poland, Belgium, Bulgaria, Croatia, Puerto Rico, Romania, Serbia, South Africa
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United States, India, Czechia, Canada, Latvia, United Kingdom, Portugal, Serbia, Poland, Romania, Brazil, Russian Federation, Slovakia, Bulgaria, Mexico, Germany, Greece, Israel